Bio Solution Co.,Ltd.'s latest marketcap:
As of 06/24/2025, Bio Solution Co.,Ltd.'s market capitalization has reached $147.75 M. According to our data, Bio Solution Co.,Ltd. is the 21843th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 147.75 M |
| Revenue (ttm) | 6.05 M |
| Net Income (ttm) | -937,666.43 |
| Shares Out | 23.89 M |
| EPS (ttm) | -0.04 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Bio Solution Co.,Ltd.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/24/2025 | ₩147.75 M | 23.12% | 21843 |
| 12/30/2024 | ₩172.51 B | 10.88% | 22353 |
| 12/28/2023 | ₩155.58 B | 82.92% | 21916 |
| 12/29/2022 | ₩85.05 B | -50.94% | 24894 |
| 12/30/2021 | ₩173.35 B | -26.16% | 20715 |
| 12/30/2020 | ₩234.76 B | -31.35% | 16360 |
| 12/30/2019 | ₩341.96 B | 33.67% | 12867 |
| 12/28/2018 | ₩255.82 B | 13285 |
Company Profile
About Bio Solution Co., Ltd.
Bio Solution Co., Ltd. is a global leader in the development, manufacturing, and sale of innovative cell therapy products. Headquartered in Seoul, South Korea, the company has been at the forefront of regenerative medicine since its founding in 2000.
Key Products and Solutions
- CartiLife: An autologous chondrocyte cell-based therapy designed to treat articular cartilage defects.
- KeraHeal-Allo: A thermosensitive hydrogel-type allogenic keratinocyte therapy for deep 2nd-degree burn wounds.
- KeraHeal: An autologous spray-type keratinocyte therapy for skin wound treatment.
Reconstructed Human Micro-Tissue Models
The company offers advanced tissue models for research, including:
- KeraSkin (epidermis model), KeraSkin-FT (full-thickness skin model), and KeraSkin-M (pigmented skin model).
- Corneal, airway mucosa (SoluAirway), and oral mucosa (SoluOral) models.
- Specialized models like SoluDPNeuron (dopaminergic neuron), SoluDANeuron (islet model), and SoluLiver (liver model).
Additional Offerings
- Human-derived primary cell cultures for in vitro research.
- Bio-advanced materials and cosmetics raw materials.
Company Background
Formerly known as MCTT Bio Co., Ltd., the company rebranded to Bio Solution Co., Ltd. in January 2016. With over two decades of expertise, it continues to pioneer breakthroughs in cell therapy and regenerative medicine.
Frequently Asked Questions
-
What is Bio Solution Co.,Ltd.'s (KOSDAQ-086820) current market cap?As of 06/24/2025, Bio Solution Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $147.75 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Bio Solution Co.,Ltd. (KOSDAQ-086820) rank globally by market cap?Bio Solution Co.,Ltd. global market capitalization ranking is approximately 21843 as of 06/24/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.